Acetobromo-α-D-glucuronic acid methyl ester is used to synthesize HMR1098-S-glucuronic acid methyl ester, a new K-ATP blocker, which can be used as a drug to prevent sudden cardiac death.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.